Heidemann, BE;
Koopal, C;
Bots, ML;
Asselbergs, FW;
Westerink, J;
Visseren, FLJ;
(2020)
The relation between VLDL-cholesterol and risk of cardiovascular events in patients with manifest cardiovascular disease.
International Journal of Cardiology
10.1016/j.ijcard.2020.08.030.
(In press).
Preview |
Text
Asselbergs_The relation between VLDL-cholesterol and risk of cardiovascular events in patients with manifest cardiovascular disease_AOP.pdf - Published Version Download (761kB) | Preview |
Abstract
INTRODUCTION: Apolipoprotein B containing lipoproteins are atherogenic. There is evidence that with low plasma low density lipoprotein cholesterol (LDL-C) levels residual vascular risk might be caused by triglyceride rich lipoproteins such as very-low density lipoproteins (VLDL), chylomicrons and their remnants. We investigated the relationship between VLDL-cholesterol (VLDL-C) and recurrent major adverse cardiovascular events (MACE), major adverse limb events (MALE) and all-cause mortality in a cohort of patients with cardiovascular disease. METHODS: Prospective cohort study in 8057 patients with cardiovascular disease from the UCC-SMART study. The relation between calculated VLDL-C levels and the occurrence of MACE, MALE and all-cause mortality was analyzed with Cox regression models. RESULTS: Patients mean age was 60 ± 10 years, 74% were male, 4894 (61%) had coronary artery disease, 2445 (30%) stroke, 1425 (18%) peripheral arterial disease and 684 (8%) patients had an abdominal aorta aneurysm at baseline. A total of 1535 MACE, 571 MALE and 1792 deaths were observed during a median follow up of 8.2 years (interquartile range 4.512.2). VLDL-C was not associated with risk of MACE or all-cause mortality. In the highest quartile of VLDL-C the risk was higher for major adverse limb events (MALE) (HR 1.49; 95%CI 1.16-1.93) compared to the lowest quartile, after adjustment for confounders including LDL-C and lipid lowering medication. CONCLUSION: In patients with clinically manifest cardiovascular disease plasma VLDL-C confers an increased risk for MALE, but not for MACE and all-cause mortality, independent of established risk factors including LDL-C and lipid-lowering medication.
| Type: | Article |
|---|---|
| Title: | The relation between VLDL-cholesterol and risk of cardiovascular events in patients with manifest cardiovascular disease |
| Location: | Netherlands |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1016/j.ijcard.2020.08.030 |
| Publisher version: | https://doi.org/10.1016/j.ijcard.2020.08.030 |
| Language: | English |
| Additional information: | This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
| Keywords: | Inflammation, Major adverse cardiovascular events, Non-HDL-C, Triglyceride rich lipoproteins, VLDL-C, Vascular disease |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Health Informatics |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10110053 |
Archive Staff Only
 |
View Item |
